Senti Biosciences Holdings, Inc. (SNTI) stock
SNTINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.10−0.04 (-28.68%)
Close on Nov 17, 2026Market cap $3.02MP/E –Yield –
Senti Biosciences price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Senti Biosciences's price to sales ratio was 29.4× on Oct 31, 2024, against 3.1× a year earlier. Over the last 3 years it ranged from 1.5× to 35.8×, with a median of 10.1×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2024 | Oct 31, 2024 | 29.4× | +18.2 |
| 2023 | Dec 29, 2023 | 11.2× | −1.1 |
| 2022 | Dec 30, 2022 | 12.3× | – |
See a number that looks wrong?